You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer
John Wiley & Sons, Ltd, January 2018
Nicholas LX Syn, Ian Wee, Andrea Li-Ann Wong, Robby M Goh, Samuel Guan-Wei Ow, Matteo Lambertini, Soo-Chin Lee
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||2||100%|
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||4||25%|
|Student > Master||3||19%|
|Student > Bachelor||3||19%|
|Student > Postgraduate||1||6%|
|Readers by discipline||Count||As %|
|Nursing and Health Professions||2||13%|
|Biochemistry, Genetics and Molecular Biology||2||13%|
|Pharmacology, Toxicology and Pharmaceutical Science||1||6%|